Sachin Jain - Aug 9, 2021 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Sachin H. Jain pursuant to Power of Attorney filed herewith.
Stock symbol
CSII
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/11/2021, 07:23 PM
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSII Common Stock Award $0 +1.45K $0.00 1.45K Aug 9, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSII Restricted Stock Units Award $0 +3.81K $0.00 3.81K Aug 9, 2021 Common Stock 3.81K Direct F3
holding CSII Restricted Stock Units 1.33K Aug 9, 2021 Common Stock 1.33K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock received at the election of the reporting person, in lieu of cash payment, as a retainer for service as a director of the Company during fiscal year 2022.
F2 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F3 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.